Pa. Xarelto Plaintiffs Request to Amend Master Complaint

Introduction

More than 1,800 product liability claims involving Johnson & Johnson and its subsidiary Janssen Pharmaceuticals’ blood thinner Xarelto are awaiting trial in Philadelphia Court of Common Pleas, and trials for three Xarelto lawsuits are expected to begin this April.

A request to make changes to the Master Complaint was put before the Philadelphia Court of Common Pleas by the remaining Pennsylvania plaintiffs to give them time to “reorganize the allegations and provide more details about the actions and inactions that form the bases of already-existing causes of action.” This request is strongly opposed by the defendants.

There are nearly 18,000 Xarelto federal product liability claims consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana.

Comments

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

Pa. Xarelto Plaintiffs Request to Amend Master Complaint